Pharmaceutical excipients are inert substances, other than the pharmacologically active drug, which are included in the manufacturing process or are present in the pharmaceutical product dosage form. Excipients are widely used in drug formulation to provide long-term stability, add bulkiness to solid formulations and facilitate drug absorption. They also enhance the overall safety or functionality of the product during storage or use. The world excipient market volume is estimated to reach 728.4 kilo tons by 2020, accounting for a revenue of $6.4 billion.
The world excipients market is driven by the increase in demand for oral solid pharmaceutical drugs and emergence of novel therapeutics on account of the upsurge in the number of pharmaceutical industries. The amalgamation of drug formulation and nanotechnology in pharmaceutical excipients have led to the development of nano-coated tablets, nano-derived liposomes, and vaccines. In addition, several companies have targeted the emerging economies for expansion of their plants for manufacturing pharmaceutical excipients, owing to cost-effective labor. However, higher production cost and stringent government regulations are likely to impede the market growth.
This report segments the world excipient market on the basis of type, function, and geography. Based on type, the market is segmented into organic and inorganic chemicals. Organic chemicals are further categorized into carbohydrates and petrochemicals. Based on function, the world market is classified into fillers and diluents, binders, coatings, flavoring agents, disintegrants, colorants, and others. The market has been analyzed on the basis of regions, namely North America, Europe, Asia-Pacific, and LAMEA. The North American excipient market is the leading revenue-generating region, owing to growing demand for solid oral drugs for the treatment of chronic diseases. However, the Asia-Pacific market is expected to register the highest CAGR, owing to low cost of raw materials and availability of cost-effective workforce.The key companies profiled in this report include Ashland, Inc., BASF SE, Associated British Foods Plc, Akzo Nobel N.V., Evonik, Merck, J.M. Huber Corporation, Dow Chemicals Corporation, Merck Millipore, Croda International, and Archer Daniels Midland. These companies have adopted product launch as their key developmental strategy to expand their market presence.
KEY BENEFITS FOR STAKEHOLDERS:
Market By Type
Market By Function
Market By Geography
SIMILAR MARKET STUDIES
This report splits Onychomycosis (Tinea Unguium) Drug by Product Drug Form, by Product Usage Type. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. And this report mainly introduces volume and value market share by players, by regions, by product type, by consumers and ...
July 2017 | $3250 | View Details >>
This report studies the Botulinum Toxins market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Botulinum Toxins market by product type and applications/end industries. The global ...
July 2017 | $2960 | View Details >>
In this report, the global Phyto Squalane market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, ...
July 2017 | $2900 | View Details >>
In this report, the global Shark Squalane market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, ...
July 2017 | $2900 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research